Angelman Syndrome Study

The purposes of this study are to gain a better understanding of the disease progression of Angelman syndrome, to follow the natural history of the clinical features of Angelman syndrome and to gain a better understanding of the clinical differences between the various genetic mechanisms of Angelman syndrome.

Official Study Website

Rare Disease Network

Study Participation

Eligible participants include individuals from birth to 60 years who have had genetic testing and have a documented molecular diagnosis of Angelman syndrome OR patients with a clear clinical diagnosis of Angelman syndrome who do not have a known molecular defect.

For more information, see the Angelman syndrome study fact sheet or contact This email address is being protected from spambots. You need JavaScript enabled to view it. , study coordinator.